Top Sell
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Karyopharm Therapeutics Inc. | 8 | 1 | 3 | 0 | €0.72 | €5.49 | 664.680% |
| Intellia Therapeutics Inc | 15 | 1 | 2 | 0 | €18.86 | €60.53 | 221.018% |
| Gritstone Oncology Inc | 6 | 1 | 2 | 0 | €0.41 | €3.68 | 790.218% |
| Syros Pharmaceuticals Inc. | 9 | 1 | 2 | 0 | €1.41 | €12.01 | 751.454% |
| Aspira Womens Health Inc. | 1 | 1 | 1 | 0 | €0.83 | €4.99 | 501.494% |
| Agenus Inc. | 4 | 2 | 1 | 0 | €0.41 | €37.02 | 8846.834% |
| Trevena Inc. | 2 | 23 | 0 | 2 | €0.15 | €6.48 | 4136.601% |
| Biofrontera AG | 0 | 1 | 0 | 0 | €0.33 | - | - |
| Fate Therapeutics Inc. | 3 | 3 | 0 | 0 | €3.20 | €7.31 | 128.307% |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.12 | - | - |
| Medigene AG | 1 | 1 | 0 | 0 | €1.06 | - | - |
| Viking Therapeutics Inc | 4 | 1 | 0 | 1 | €49.90 | - | - |
| Protalix Biotherapeutics Inc. | 1 | 1 | 0 | 0 | €0.96 | €2.00 | 108.290% |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | €0.34 | €21.06 | 6072.333% |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €36.00 | €50.00 | 38.889% |
| Rocket Pharmaceuticals Inc | 2 | 1 | 0 | 0 | ? | €32.00 | 91.674% |
| Enlivex Therapeutics Ltd. | 0 | 1 | 0 | 0 | €1.10 | - | - |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.07 | €50.00 | 4586.036% |
| Glycomimetics Inc. | 3 | 7 | 0 | 4 | €0.15 | €9.13 | 6022.386% |
| Cara Therapeutics Inc. | 10 | 7 | 0 | 3 | €0.29 | €4.61 | 1485.842% |
| Bellicum Pharmaceuticals Inc. | 0 | 10 | 0 | 0 | €0.064 | - | - |
| Salarius Pharmaceuticals Inc. | 0 | 1 | 0 | 0 | €0.39 | - | - |
| B.R.A.I.N. Biotechnology Research and Information Network AG | 0 | 1 | 0 | 0 | €1.56 | - | - |
| Coherus Bioscien. | 0 | 2 | 0 | 0 | €1.18 | - | - |
| Atara Biotherapeutics Inc. | 2 | 2 | 0 | 0 | €0.37 | €3.00 | 716.549% |